Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$1.13|
|52 Week High||AU$0.82|
|52 Week Low||AU$2.19|
|1 Month Change||-8.87%|
|3 Month Change||-1.74%|
|1 Year Change||9.18%|
|3 Year Change||201.33%|
|5 Year Change||2,356.52%|
|Change since IPO||707.14%|
Recent News & Updates
|AHI||AU Software||AU Market|
Return vs Industry: AHI underperformed the Australian Software industry which returned 30.7% over the past year.
Return vs Market: AHI underperformed the Australian Market which returned 24.3% over the past year.
Stable Share Price: AHI is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: AHI's weekly volatility (10%) has been stable over the past year.
About the Company
Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan.
Advanced Human Imaging Fundamentals Summary
|AHI fundamental statistics|
Is AHI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AHI income statement (TTM)|
|Cost of Revenue||AU$9.89m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.10|
|Net Profit Margin||-2,166.06%|
How did AHI perform over the long term?See historical performance and comparison
Is Advanced Human Imaging undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AHI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AHI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AHI is unprofitable, so we can't compare its PE Ratio to the Australian Software industry average.
PE vs Market: AHI is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AHI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AHI is overvalued based on its PB Ratio (78.3x) compared to the AU Software industry average (5.2x).
How is Advanced Human Imaging forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Software industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Advanced Human Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Advanced Human Imaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AHI is currently unprofitable.
Growing Profit Margin: AHI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AHI is unprofitable, and losses have increased over the past 5 years at a rate of 16.3% per year.
Accelerating Growth: Unable to compare AHI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AHI is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (37.5%).
Return on Equity
High ROE: AHI has a negative Return on Equity (-710.84%), as it is currently unprofitable.
How is Advanced Human Imaging's financial position?
Financial Position Analysis
Short Term Liabilities: AHI's short term assets (A$4.0M) exceed its short term liabilities (A$3.4M).
Long Term Liabilities: AHI's short term assets (A$4.0M) exceed its long term liabilities (A$51.2K).
Debt to Equity History and Analysis
Debt Level: AHI's debt to equity ratio (110.1%) is considered high.
Reducing Debt: Insufficient data to determine if AHI's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AHI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AHI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.8% each year
What is Advanced Human Imaging current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AHI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AHI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AHI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AHI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AHI's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Vlado Bosanac (55 yo)
Mr. Vlado Bosanac has been Chief Executive Officer and Executive Director of Advanced Human Imaging Limited (formerly known as MyFiziq Limited) since October 17, 2016. He is the Founder of Advanced Human I...
CEO Compensation Analysis
Compensation vs Market: Vlado's total compensation ($USD1.70M) is above average for companies of similar size in the Australian market ($USD301.81K).
Compensation vs Earnings: Vlado's compensation has increased whilst the company is unprofitable.
Experienced Management: AHI's management team is considered experienced (4 years average tenure).
Experienced Board: AHI's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.9%.
Advanced Human Imaging Limited's employee growth, exchange listings and data sources
- Name: Advanced Human Imaging Limited
- Ticker: AHI
- Exchange: ASX
- Founded: 2014
- Industry: Application Software
- Sector: Software
- Market Cap: AU$154.036m
- Shares outstanding: 136.92m
- Website: https://www.advancedhumanimaging.com
- Advanced Human Imaging Limited
- 71-73 The Esplanade
- Unit 5
- South Perth
- Western Australia
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/27 07:01|
|End of Day Share Price||2021/10/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.